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doi:10.1016/j.ejvs.2010.11.004Abstract Introduction: Mural thrombus of the thoracic aorta is a rare clinical finding in the
absence of aneurysm or atherosclerosis.
Methods: The medical records of all patients diagnosed with a thrombus of a non-aneurysmatic
and non-atherosclerotic descending thoracic aorta (NAADTA) and treated by the senior author
between 04/1997 and 04/2010 were reviewed.
Results: Eight patients with mural thrombus of the NAADTA were identified. Arterial embolism
was the main clinical finding in all cases and involved the lower extremities (n Z 6), mesen-
teric (n Z 3) or renal arteries (n Z 2). Hypercoagulable disorders were present in 3 cases
and a concurrent malignancy in another 3. Two patients underwent open surgery while 4
patients were treated conservatively with anticoagulation. Of the remaining 2 patients, one
was treated with a thoracic stent-graft and aorto-biiliac bypass and the other one with trans-
femoral thrombectomy. Technical success was achieved in all surgical cases and thrombus
resolution or stable disease in the conservative management group. No thrombus recurrence
was observed during a mean follow-up of 49 months.
Conclusion: The management of mural thrombus in NAADTA represents a challenge, especially
in case of malignant disease or hypercoagulable disorder as a potential underlying pathologyeducation questions on this paper, please go to www.vasculareducation.com and click on ‘CME’
0 2638 3701; fax: þ49 30 2638 3705.
iskus-berlin.de (R.I. Ru¨ckert).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Embolism from Thrombus in the Normal Aorta 451and should be individualized. Although no consensus exists in the literature, therapeutic antic-
oagulation is proposed as first-line therapy. The indication for surgical intervention results
from contraindication to anticoagulation, mobile thrombus or recurrent embolism. Whenever
possible, endovascular therapy should be preferred.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Distal arterial embolism is a relatively common problem that
carries increased morbidity and, potentially, mortality. The
amputation rate following acute limb ischaemia is estimated
at 13e14% while mortality is at 9e12%.1 Over 80% of all
peripheral and visceral emboli originate fromdisturbances of
cardiac function itself such as atrial fibrillation, myocardial
infarction, endocarditis and prosthetic heart valves. Non-
cardiac causes include aortic pathologies such as aneurysmal
lesions, dissections, penetrating ulcers or traumatic lesions.2
Since 1967 when Oliver et al.3 published the first
described case of thrombo-embolism from the thoracic
aorta, few case reports and small series of patients with
thrombus in a non-aneurysmal thoracic aorta have been
published.48 In most of these cases, peripheral embolism
was the initial clinical manifestation. The expanding
availability of advanced diagnostic modalities such as
computed tomography (CT), trans-esophageal echocardi-
ography (TEE) and magnetic resonance imaging (MRI)
increasingly made possible the accurate diagnosis of this
aortic pathology over the past decade.5,9,10
The optimal management of these patients is still
controversial and depends on the location and morphology
of the thrombus, the symptoms and the general condition
of the patient. The presence of a floating thrombus in the
thoracic aorta is associated with a high risk of peripheral
embolism.5 The primary objective of this study is to report
our experience regarding the diagnosis and management of
thrombus in the non-aneurysmal, non-atherosclerotic
descending thoracic aorta (NAADTA).
Patients and Methods
Themedical recordsofall patientsdiagnosedwith thrombus in
an NAADTA and treated by the senior author were reviewed
retrospectively. For the descending thoracic aorta, aneu-
rysmal dilatation was defined as an aorta at least twice the
diameter of the patient’s contiguous normal aortic calibre.
The presence of atherosclerosis was graded based on the
amount of calcification identified on the CT scan. Data
collection included patient demographics, risk factors for
vascular disease, symptoms leading to diagnosis, relevant co-
morbidities, diagnostic and therapeutic management and
outcome. Treatment complications and the follow-up outpa-
tient-clinic evaluations were reviewed. All imaging studies
were evaluated independently by vascular radiologists.
Results
In a period of 12 years, 8 patients (7 female, 1 male) were
identified with thrombus in an NAADTA. The mean age of
the patients was 55 years (range, 45e68). Furtherdemographic data and clinical findings of the patients are
summarised in Table 1.
Diagnostic management
The diagnostic work-up that revealed intraluminal aortic
thrombus was prompted by lower extremity embolism in 6
cases and mesenteric embolism in 1 case. In an additional
case, it was an incidental finding in a staging CT scan for
malignant melanoma. Imaging modalities included multi-
detector CT scan alone or in conjunction with magnetic
resonance angiography (MRA) and TEE in all cases, while
digital subtraction angiography (DSA) was performed on
demand. Screening for hypercoagulable disorders was per-
formed in all cases prior to initiation of treatment.
The thrombus was localised in zone III of the thoracic
aorta in 5 patients and extended to the visceral abdominal
aorta in three cases. The sites of arterial embolism involved
primarily the lower extremity arteries and, less frequently,
the visceral arteries (Table 1).
Characteristics of aortic lesions e underlying
pathologies
None of the patients had concomitant aortic or cardiac
pathologies such as aneurysm, penetrating aortic ulcer,
severe atherosclerosis or calcification of the thoracic aortic
wall or intracardial thrombus. One patient had an aortic wall
angiosarcoma, which was associated with mural thrombus
formation. The abdominal aorta, as well as the iliac arteries,
was free of aneurysmal disease or other pathology, which
could account for peripheral embolism.Minimal calcification
of the abdominal aorta was present in 3 out of 8 patients.
The screening for hypercoagulable disorders revealed
anti-phospholipid syndrome in 1 patient and heparin-
induced thrombocytopenia (HIT) type II in another. Although
not diagnosed primarily, one patient underwent repeated
extensivework-up for thrombophilia during follow-up,which
eventually revealed elevated serum levels of plasminogen
activator inhibitor-1 (PAI-1), positive antinuclear antibodies
(ANAs) and anti-neutrophil cytoplasmic antibodies (ANCAs),
suggesting the diagnosis of sub-clinical vasculitis. Concur-
rent malignancies were present in three patients and
included stage IV malignant melanoma, myeloproliferative
malignancy and intimal sarcoma of the thoracic aorta.11
The thrombus was sessile in 5 cases and pedicled in 3.
Therapeutic management
Four patients were treated conservatively. Two were
placed on intravenous heparin followed by oral anti-
coagulation with coumadin derivatives, while one patient
with Rutherford class I chronic limb ischaemia due to
Table 1 Demographic and clinical data of all 8 patients with a thrombus of a non-aneurysmal and non-atherosclerotic
descending thoracic aorta.
Patient
(gender, age)
Localization of
emboli
Relevant
concomitant
disease
Diagnosis Therapy FU
(ms)
Result
No. 1 (female,
45 years)
Bilateral common
femoral arteries,
superior mesenteric
artery
Heparin-induced
thrombocytopenia
type II
TEE, DSA,
CT
Fogarty manoeuvre,
embolectomy,
Coumadin derivatives
122 No recurrence
No. 2 (female,
64 years)
Bilateral popliteal
and crural arteries
Aortic sarcoma TEE, MRA,
CT
Resection, Aspirin 18 Died from
metastases
No. 3 (female,
56 years)
Bilateral common
femoral arteries,
deep femoral and
popliteal arteries
Unknown TEE, CT Conservative,
Coumadin derivatives
20
(lost to FU)
No recurrence
No. 4 (female,
51 years)
Mesenteric arteries Elevated values
of plasminogen
activator
inhibitor-1
TEE, MRA,
CT
Resection, aortic
replacement,
Coumadin derivatives
88 No recurrence
No. 5 (female,
68 years)
Right common iliac
artery and common
femoral artery, right
renal artery, celiac
trunk
Antiphospholipid
syndrome
TEE, CT Conservative,
Coumadin derivatives
78 No recurrence
No. 6 (female,
53 years)
Infrarenal aorta,
bilateral
common and external
iliac arteries
Myeloproliferative
malignancy-essential
thrombocytosis
TEE, DSA,
CT
Complex repair incl.
stent-graft
and aortobifemoral
bypass
Aspirin (patient declined
Coumadin derivatives)
51 No recurrence
No. 7 (male,
57 years)
Left common iliac
artery,
right femoral
artery
Malignant melanoma TEE, CT Conservative, Aspirin (due
to advanced
metastatic disease)
12 Persistent
thrombus,
no progression
No.8 (female,
49 years)
Bilateral popliteal
and
crural arteries
Unknown TEE, CT Conservative, Aspirin
(no compliance
for Coumadin derivatives)
3 Thrombus
resolution
FU, follow-up; ms, months; DSA, digital subtraction angiography; TEE, trans-esophageal echocardiography; MRA, magnetic resonance
angiography; CT, computed tomography.
452 N. Tsilimparis et al.chronic occlusion of the left iliac artery and stage IV
malignant melanoma was only given Aspirin, due to the
advanced tumour disease and the stability of the mural
thrombus. The choice of conservative treatment was based
on the presence of significant co-morbidities in the first
patient (Fig. 1(a)e(c)) and advanced malignancy in the
latter patient. The third patient had a known anti-phos-
pholipid syndrome and a sessile thrombus of the thoracic
aorta. The fourth patient had been therapeutically hep-
arinised during the thromboembolectomy of the lower
extremities and maintained on anticoagulation thereafter.
However, a four-compartment fasciotomy was eventually
necessary. Follow-up CT scan 2 months later showed
complete resolution of the aortic thrombus.
Surgical treatment was pursued in 4 patients. One
patient at high risk for thoracotomy underwent a less-
invasive procedure with transfemoral thrombectomy with
a Fogarty catheter under fluoroscopic guidance and bilat-
eral femoral thromboembolectomies, recognising the risk
of visceral or renal embolisation. Due to unrecognisedmesenteric embolism during the procedure, open surgery to
remove embolic material from the superior mesenteric
artery was necessary a day later.
The second patient with intimal sarcoma of the thoracic
aortic wall and liver metastases underwent palliative exci-
sion of the aortic tumour and direct closure of the aorta.11
In the third patient of that group, an aortic tumour was
suspected on CT scan. To achieve complete tumour
resection, a segmental resection of the descending
thoracic aorta and interposition of a Dacron graft was
performed after establishment of an arterioearterial
extracorporeal circulation with the BioMedicus pump
(Medtronic, Eden Prairie, MN, USA). However, malignancy
was not confirmed on histopathologic examination. At the
10-year follow-up after aortic replacement, the patient
underwent repeat extensive work-up for thrombophilia,
which eventually revealed elevated values of PAI-1. The
last patient treated surgically had extensive thrombus in
the descending thoracic and pararenal aorta and a chronic
infrarenal aortic occlusion, possibly due to prior embolic
Figure 1 Thoracic CT scan of a 68-year-old female patient with a large sessile thrombus in the NAADTA. Because of acute arterial
occlusion with incomplete ischaemia of the right lower extremity embolectomy had been performed from the right common
femoral and external iliac arteries. The axial view (a) shows the impairment of the aortic lumen leading to an asymptomatic
embolic occlusion of the celiac trunk (b, saggital view) and of the right renal artery (c, frontal view).
Embolism from Thrombus in the Normal Aorta 453events. The occlusive disease was associated with a Ruth-
erford class III chronic limb ischaemia. The initial opera-
tion included an aortobifemoral bypass after transaortic
balloon thrombectomy of the thoracic aorta with tempo-
rary occlusion of the visceral vessels. Due to the presence
of residual thrombus in the thoracic aorta as demonstrated
on the postoperative CT scan, a transfemoral thoracic
stent-graft (Zenith, TX1, 30/80 mm William Cook Europe,
Bjaerverskov, Denmark) was used to cover the involved
segment of the thoracic aorta and prevent further embo-
lism (Fig. 2(a)e(c)).
Outcomes and follow-up
Follow-up for both surgical and conservative treatment
groups included regular office visits and thoraco-abdominal
CT scans. CT scans were performed every 6 months for the
first 2 years and individually thereafter.
The intraluminal thrombus had completely resolved in
both patients treated with coumadin derivatives, and no
recurrence was observed on follow-up imaging. One
patient with anti-phospholipid syndrome was maintainedFigure 2 Extensive thrombus in the descending thoracic and supr
syndrome with chronic infrarenal occlusion including the aortic bifu
the thoracic descending aorta (a) and digital subtraction angio
(b) demonstrating extensive narrowing of the thoracic aorta due
dimensional CT demonstrating the final result of the two-staged rep
cover the residual thrombus in the thoracic aorta (c).on lifelong anticoagulation, while the other patient in the
conservative group was switched to Aspirin 12 months
later following an upper gastrointestinal bleed. The latter
patient was lost to follow-up after 20 months. The
patient with malignant melanoma treated with Aspirin
alone showed no progression of the initially sessile,
circumferential mural thrombus and there were no
further signs of peripheral embolism. Therefore, conser-
vative therapy was continued indefinitely. The fourth
patient treated conservatively, was given Aspirin therapy
lifelong due to poor compliance with coumadin
derivatives.
The postoperative course of the surgically treated
patients was uneventful and no adverse event or thrombus
recurrence was diagnosed during follow-up. Anticoagulation
in the surgically treated group of patients included coumadin
derivatives in 2 patients. Onepatientwas put on Aspirin after
resection of the aortic sarcoma, which had caused the
thrombus, while the second patient declined oral anti-
coagulation with coumadin derivatives. The patient with
aortic sarcoma died of generalised metastases 18 months
after the operation.a- and interrenal aorta of a 53-year-old female causing Leriche
rcation, possibly due to prior embolic events. Axial CT scan of
graphy of the distal thoracic and proximal abdominal aorta
to thrombus formation and infrarenal aortic occlusion. Three-
air with secondary transfemoral implantation of a stent-graft to
454 N. Tsilimparis et al.Discussion
The incidence of aortic mural thrombus was reported by
Machleder et al.12 to be as low as 0.9% (95 cases) in a study of
10,671 autopsies. Only about half of these patients had
aneurysmal disease and only 17% of the patients had
evidence of peripheral embolism. The authors described the
nature of the thrombus as a distinct entity in many cases.
During the same time period, only 2 cases of symptomatic
aortic mural thrombus were treated at that institution.
The true incidence of mural thrombus in NAADTAs is
unknown but it is possibly much higher than that reported
in the literature.
The reported cases of mobile thrombus in the thoracic
aorta were limited to 100 published cases in a review by
Choukroun et al.10 In an additional review of the literature
since 2002, we were able to identify about 50 more cases,
including a few small series.1319
In most cases, the thrombus was located in the descend-
ing thoracic aorta, although the presence of thrombus in the
aortic arch as well as in the abdominal aorta has been
described.10,20
The aetiology of thrombus formation in amacroscopically
normal aorta is not well understood. A correlation with
underlying malignant disease, hypercoagulable disorders,
primary endothelial disorders or even iatrogenic causes has
been suggested (Table 2).7,18,19,2124 Advanced but not early
atherosclerotic lesions can be identified on CT images from
the presence of calcifications and aortic wall irregularities.
The presence of tumour in the thoracic aorta could be
a predisposing factor for thrombus formation. Most aortic
sarcomas were diagnosed following aortic thrombus forma-
tion complicated with peripheral or visceral embolism.25,26
Similarly, in our series, a suspicious intraluminal growthTable 2 Underlying pathologies described for the pres-
ence of thrombus in the non-aneurysmal, non-atheroscle-
rotic thoracic aorta.
Predisposing factor
Essential thrombocytemia7,35,43
Protein C or S deficiency7,18,20,44,45
AntiphosPholipid syndrom23,46,47
Heparin-induced thrombocytopenia48,49
Hyperhomocysteinaemia15,20
Iatrogenic (e.g. intraaortic balloon pumping)50,22
Aortic wall tumor51
Cancer20,24,44,47,52
Chemotherapy53,54
Homozygous plasminogen activator inhibitor type 1 (PAI-1)-
675(4G) and heterozygous GP Ia 807C/T genotypes8
Factor V Leiden55
Familial dysfibrinogenemia20
Antithrombin III deficiency20
Blunt aortic trauma19,21,56
Drug abuse4
Elevated Factor VIII57
Aspergilloma58
Rheumatic disease59,60proved to be an aortic sarcoma. In patients with aortic mural
thrombus, it is very important to evaluate the aortic wall
thoroughly and consider always the possibility of a local
malignancy. However, the differential diagnosis between
mural thrombus with or without aortic wall malignancy can
be difficult in certain cases (patient No. 4, Table 1).
In the present series, 6 out of 8 patients had a concurrent
hypercoagulable state as a possible underlying mechanism.
Several publications8,18 have demonstrated that genetic
and thrombophilic factors could be associatedwith thrombus
formation in the NAADTA. Recent advances in genetic diag-
nosis have shown a correlation between certain genetic
patterns and thrombus formation at other vascular sites.27 A
thorough genetic and hypercoagulability work-up should be
performed in all patients with thrombus in the NAADTA. It is
possible that, in the earlier years of this series, somepatients
were not screened to today’s standards due to technical
limitations at that time.
Thrombus formation in the thoracic aorta is encountered
with increasing frequency over the past 10 years. This is
mainly through the use of advanced imaging as part of
thorough work-up to identify the source of peripheral or
visceral embolism. In most centres, standard postoperative
evaluation of patients with peripheral embolism includes
24-h electrocardiography (ECG), TEE, CTangiography or
MRA of the thoraco-abdominal aorta and arterial duplex
ultrasound of the vessels proximal to the embolic occlusion.
Several authors have earlier reported TEE to be an
adequate method for detecting mural thrombus of the
thoracicaorta,9with somesuggestingTEE tobecomparatively
more sensitive than CTorMRA.28 However, these studies were
published before recent advancements in CT and MR imaging
with high-resolution scanners.
Of the 8 patients in our series, 7 were diagnosed during
the work-up for lower extremity or mesenteric ischaemia.
In general, mural thoracic aortic thrombus is rarely diag-
nosed before becoming symptomatic.
The definitions regarding thrombus material in the
thoracic aorta are relatively unclear because no consistent
nomenclature exists and the terms ‘mobile’, ‘floating’,
‘sessile’ or ‘pedicled’ were, in all cases, defined by the
treating physicians. Due to the limited number of cases, the
optimal treatment is often debatable and different
approaches have been suggested. Several authors29,30 have
described catheter-guided thrombolysis to treat mural
aortic thrombus, a therapy that has later been associated
with a significant risk of additional peripheral embolism. In
particular, there is the potential danger of lysing pedun-
culated lesions, releasing the bulk of the thrombus and
causing massive embolisation.30
Other series have demonstrated that therapeutic oral
anticoagulation is an efficient and safe option in patients
with aortic mural thrombus.20,31 However, a careful patient
selection is necessary, as cases of persistent or recurrent
embolism under coumadin derivatives have been
described.32 The proposed duration of oral anticoagulation
varies among authors, ranging in time from complete
resolution of the thrombus to lifelong. In a review of
patient outcomes in 23 cases, complete thrombus resolu-
tion occurred in 74% (n Z 17) of the cases.6,7,10,31,33e35
In one of the largest series reported so far, Choukroun
et al.10 suggested that surgical treatment should be
Embolism from Thrombus in the Normal Aorta 455reserved for patients not responding with thrombus reso-
lution on follow-up TEE after 2 weeks of therapeutic anti-
coagulation with heparin. In this series as well as in earlier
series, surgical treatment included thrombectomy and
segmental aortic resection. Segmental aortic resection
provides the optimal treatment in patients with neoplasms
of the thoracic aorta as an underlying cause for thrombus
formation. In these cases, en-bloc resection with negative
margins should invariably be attempted, unless limited by
extensive metastatic disease.
Our literature review identified 8 cases of patients with
thrombus of the thoracic aorta treated with sten-
tgrafts.17,32,36e41 A favourable outcome without complica-
tions was described in all cases. However, the risk of distal
embolism during wire manipulation and stent-graft
deployment could represent a limitation of endovascular
treatment. Nevertheless, no such complications were
described in the reported cases. Full entrapment of the
thrombus between the stent-graft and the aortic wall
should be achieved. Therefore, the required length of the
graft should be at least 2 cm proximally to 2 cm distally to
the longitudinal extension of the thrombus. We preferred
an oversizing of the stent-graft by 5e10%.
In general, no clear guidelines exist regarding the optimal
management of these patients. Possible reasons, therefore,
include the rarity of the disease, the limited available
experience and the protean pathophysiology. Most authors
would treat patients with sessile aortic wall thrombus using
intravenous heparin followed by oral therapeutic anti-
coagulation.9,10 However, the choice of patients requiring
surgery and what is the best surgical approach remain
controversial issues.42
In our clinical practice, all patients are placed initially on
intravenous heparin anticoagulation. Factors determining
subsequent management include the patient’s co-morbid-
ities, thrombus size and morphology, current symptoms and
risk factors predisposing to thrombus formation. Patients
with concurrent malignancy, coagulation disorders and
sessile thrombi are preferably treated conservatively.
When a mobile thrombus is encountered or recurrent
episodes of embolism from a sessile thrombus despite
therapeutic anticoagulation occur, we advocate an endo-
vascular approach using a stent-graft to fix the thrombus to
the aortic wall. We reserve open repair for cases not suit-
able for endoluminal treatment or for patients with sus-
pected malignancy.
One of the limitations of this retrospective study is that
it covers a time period of 12 years with current diagnostic
and therapeutic modalities not being available in the
earlier cases.
Conclusion
Thrombus in the descending, otherwise ‘healthy’, thoracic
aorta represents an underdiagnosed medical entity, which
could potentially explain many cases of cryptogenic embo-
lism. An underlying cause should be thoroughly searched for,
including thrombophilia studies. Aortic wall tumour as well
as malignancy elsewhere should be excluded. Currently,
long-term anticoagulation is the most widely accepted first-
line therapy. Surgical intervention is reserved for patients
with contraindications to long-term anticoagulation or thosewho fail conservative management. We consider the pres-
ence of a mobile thrombus as a relative indication for
primary intervention due to the high risk of embolism.
Transaortic or transfemoral thrombectomy, segmental
aortic resection and stent-graft implantation are among the
surgical options with the latter gaining preference in our
institution.
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